Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

724
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
724
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

445
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
445
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

471
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

1.6K
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.6K
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

298
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
298

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cystic medial necrosis Erdheim-Gsell.

VASA. Zeitschrift fur Gefasskrankheiten·2011
Same author

Balloon sclerotherapy: a new method for the treatment of truncal varicose veins.

VASA. Zeitschrift fur Gefasskrankheiten·2008
Same author

Severe potential consequences of delayed diagnosis in patients with hip claudication.

Archives of orthopaedic and trauma surgery·2002
Same author

Repair of infrapopliteal postembolectomy complications with variant embolization techniques.

Cardiovascular and interventional radiology·2002
Same author

Measurement of the lymphatic clearance of the human skin using a fluorescent tracer.

Journal of vascular research·2001
Same author

Long-term results of percutaneous thrombo-embolectomy in patients with infrainguinal embolic occlusions.

International angiology : a journal of the International Union of Angiology·2001

Related Experiment Video

Updated: Apr 15, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

17.2K

Phlebosclerosis, phlebothrombosis, and thrombophlebitis: A current perspective.

H J Leu1, A J Leu2

  • 1From the Department of Pathology, Clinic of Internal Medicine, University of Zurich, Switzerland.

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|April 9, 2015
PubMed
Summary

Phlebosclerosis, phlebothrombosis, and thrombophlebitis are distinct venous conditions. Differentiating them is crucial for accurate diagnosis and guiding clinical investigations for better patient outcomes.

More Related Videos

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

3.3K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.9K

Related Experiment Videos

Last Updated: Apr 15, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

17.2K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

3.3K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.9K

Area of Science:

  • Vascular Biology
  • Pathology
  • Clinical Medicine

Background:

  • Phlebosclerosis, phlebothrombosis, and thrombophlebitis are distinct structural venous changes.
  • Phlebosclerosis is age-dependent fibrotic degeneration, potentially leading to thrombosis.
  • Phlebothrombosis is a serious circulatory disorder, while thrombophlebitis can be benign or systemic.

Purpose of the Study:

  • To clarify the fundamental differences between phlebosclerosis, phlebothrombosis, and thrombophlebitis.
  • To highlight the clinical significance of distinguishing these venous conditions.
  • To propose a classification and differentiation guidelines for thrombophlebitides.

Main Methods:

  • Review of existing literature on venous structural changes.
  • Histopathological analysis of venous wall alterations.
  • Clinical correlation of different phlebitis types with systemic diseases.

Main Results:

  • Phlebosclerosis is a degenerative process, not a disease, but can predispose to thrombosis.
  • Phlebothrombosis in nonvaricose veins suggests malignancy or coagulation disorders.
  • Thrombophlebitis is not linked to malignancy but can be associated with systemic vasculitides like Buerger's disease.

Conclusions:

  • Histopathological differentiation of phlebothrombosis and thrombophlebitis is critical.
  • Accurate distinction guides further clinical investigations and management.
  • A proposed classification aids in understanding and managing various thrombophlebitides.